(1S,2R)-1-(2-METHYLPHENYL)-2-[(S)-1-AZIDOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE
Compound with spectra: 1 NMR
![(1S,2R)-1-(2-METHYLPHENYL)-2-[(S)-1-AZIDOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE](/api/compound/JqoR80QB96r.png?ph=true&h=300&w=458 "(1S,2R)-1-(2-METHYLPHENYL)-2-[(S)-1-AZIDOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE")
| SpectraBase Compound ID | JqoR80QB96r |
|---|---|
| InChI | InChI=1S/C18H26N4O/c1-5-16(20-21-19)15-12-18(15,17(23)22(6-2)7-3)14-11-9-8-10-13(14)4/h8-11,15-16H,5-7,12H2,1-4H3/t15-,16+,18+/m0/s1 |
| InChIKey | GPZYOQSYXFDTOO-LZLYRXPVSA-N |
| Mol Weight | 314.43 g/mol |
| Molecular Formula | C18H26N4O |
| Exact Mass | 314.210661 g/mol |
| Enantiomer InChIKey | GPZYOQSYXFDTOO-RYRKJORJSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(1S,2R)-1-(2-NAPHTHYL)-2-[(S)-1-AZIDOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE
Spiro[N-Methylindole-2-one-3,3'-cyclohexan-2'-one]
3-Methyl-1-phenyl-4-spiro[2,3-benzodiazepine-5,1'-cyclopentane]one
1-Benzyl-1,2-dihydro-5-methyl-2-oxospiro[3H-indole-3,4'-piperidin]-1'-ium hydrochloride
1H-Isoindole-1,3(2H)-dione, hexahydro-2-(2-hydroxy-2,2-diphenylethyl)-3a,7a-bis(phenylmethyl)-, cis-
(2R,1"'R,2"'S,5"'R)-2-[(E)-2"-(3"'-Isopropyl-5"'-methylcyclohexanoxy)-1"-methylvinyl]spiro[cyclopropane-1,9'-[9'H]fluorene]
1-((2,3-Dihydro-2,3-diphenyl-2-acetyl)-carbonyl)-pyrrolidine-N-oxide
1,3-Dibenzyl-3-methyloxindole
10,10-Spirocyclohexanotetrahydropyrimido[1,2-a]indole
21,24-Diphenyldibenzo[e,n]4,7,10,13,16-pentaoxa-1,19-diazatricyclo[17.3.3.1(21,24)]hexacosan-26-one
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of derivatives of (1S,2R)-1-phenyl-2-[(S)-1-aminopropyl]-N,N-diethylcyclopropanecarboxamide (PPDC) modified at the 1-aromatic moiety as novel NMDA receptor antagonists: the aromatic group is essential for the activity | Bioorganic & Medicinal Chemistry | 2002 |